Luma Therapeutics

FDA Clears First System to Combine Smartphone Controlled UVB Light with Occlusive Hydrating Gels to Treat Inflammatory Skin Disease

Luma Therapeutics, dedicated to eradicating suffering from inflammatory skin disease, is launching illuvinateTM, an innovative and modern twist on a safe and effective treatment called the Goeckerman regimen, invented over 100 years ago by a dermatologist at the Mayo Clinic. Backed by strong clinical trial data, this system enables those suffering from chronic skin conditions such as psoriasis or eczema, to experience clear skin after performing therapy in the comfort of their own homes. - June 11, 2018